TG Therapeutics, Inc. beat EPS estimates 0% of the time across 2 reported quarters (0 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.41 | — | — | Miss |
| Q12026 FY2026 | $0.23 | $0.17 | -26.1% | Miss |
| Q42025 FY2025 | $0.35 | $0.14 | -60.0% | Miss |
Back to TGTX overview · TGTX holders · TGTX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.